Exploration of Gait Biomechanics and Muscle Pain of the Lower Extremity
NCT ID: NCT06411197
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
36 participants
INTERVENTIONAL
2023-11-08
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A) Examine how experimental muscle pain in different types of muscles (ankle plantar-flexion, knee extension, and flexion muscles) affects kinematics, kinetics, and muscle activation
Participants will receive six muscle injections: a) Hypertonic saline (painful condition) and b) Isotonic saline (control condition) in 1) m. gastrocnemius, 2) m. semitendinosus, and 3) m. biceps femoris.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Short-term Motor Training on Accuracy and Precision of Knee Movement in Human With and Without Knee Pain
NCT04146311
Reliability of the Passive Properties of the Calf Muscles in Healthy Subjects Assessed Using Isokinetic Device
NCT04191759
Electromyostimulation and Strength Walking for Knee Injuries
NCT02065518
Effect of Heel Lift Insole on Kinematics and Kinetics of the Lower Limb and Lumbar Spine Among Healthy Individuals
NCT07047300
The Effect of Experimental Knee Pain During Strengthening Exercises on Muscle Strength Gain
NCT01346995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Following the injection, there will typically be a 15-minute window of pain (45). Within this timeframe, motion capture will be carried out for both the control and painful conditions. During motion capture, the participants will perform multiple walking trials of approximately 10 meters. The participants will be equipped with electromyography (EMG) sensors on key muscles of the lower extremities. The participants will be asked for NRS ratings every 30 seconds throughout the 15 minutes with expected pain. There will be a 15-minute washout between the muscle injections.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gastrocnemius (painful condition)
1.5 mL injection of hypertonic saline (7%) to the gastrocnemius muscle.
Hypertonic saline injection
Injection with hypertonic saline (7%)
Gastrocnemius (control condition)
1.5 mL injection of isotonic saline (0.9%) to the gastrocnemius muscle.
Isotonic saline injection
Injection with isotonic saline (0.9%)
Biceps femoris (painful condition)
1.2 mL injection of hypertonic saline (7%) to the biceps femoris muscle.
Hypertonic saline injection
Injection with hypertonic saline (7%)
Biceps femoris (control condition)
1.2 mL injection of isotonic saline (0.9%) to the biceps femoris muscle.
Isotonic saline injection
Injection with isotonic saline (0.9%)
Semitendinosus (painful condition)
1.2 mL injection of hypertonic saline (7%) to the semitendinosus muscle.
Hypertonic saline injection
Injection with hypertonic saline (7%)
Semitendinosus (control condition)
1.2 mL injection of isotonic saline (7%) to the semitendinosus muscle.
Isotonic saline injection
Injection with isotonic saline (0.9%)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hypertonic saline injection
Injection with hypertonic saline (7%)
Isotonic saline injection
Injection with isotonic saline (0.9%)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Drug addiction, defined as the use of cannabis, opioids, or other drugs
* Previous or current neurologic or musculoskeletal illnesses
* Current pain
* Lack of ability to cooperate
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kristian Kjær Petersen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristian Kjær Petersen
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristian KS Petersen
Role: PRINCIPAL_INVESTIGATOR
Aalborg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aalborg University
Aalborg, North Denmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20220063-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.